ZIPEXOLE pramipexole dihydrochloride 1.5 mg tablets blister pack

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

pramipexole dihydrochloride monohydrate, Quantity: 1.5 mg

Mevcut itibaren:

Arrotex Pharmaceuticals Pty Ltd

INN (International Adı):

pramipexole dihydrochloride monohydrate

Farmasötik formu:

Tablet, uncoated

Kompozisyon:

Excipient Ingredients: silicon dioxide; povidone; mannitol; pregelatinised maize starch; magnesium stearate

Uygulama yolu:

Oral

Paketteki üniteler:

10, 30, 100

Reçete türü:

(S4) Prescription Only Medicine

Terapötik endikasyonlar:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Ürün özeti:

Visual Identification: White, circular, flat, beveled edged, uncoated tablets debossed with 'CL' and '6' debossed on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2014-09-23